PMID- 37918409
OWN - NLM
STAT- MEDLINE
DCOM- 20231106
LR  - 20231124
IS  - 1665-1731 (Electronic)
IS  - 1405-9940 (Print)
IS  - 1665-1731 (Linking)
VI  - 93
IP  - Supl
DP  - 2023
TI  - Consensus document on the use of sacubitril/valsartan in patients with heart 
      failure: Consejo Interamericano de Falla Cardiaca e Hipertension Pulmonar 
      (CIFACAH) of the Inter-American Society of Cardiology (IASC).
PG  - 1-12
LID - 10.24875/ACM.23000036 [doi]
AB  - Heart failure (HF) is a significant event for public health. It has a prevalence 
      between 1-2%, mortality rate between 7-17%, and hospitalization between 32-44%. 
      This implies a risk to health and quality of life, but also great financial 
      efforts for health systems. Sacubitril/valsartan is a medication recognized for 
      its efficacy, and this consensus seeks to synthesize the available information 
      regarding its use for the benefit of patients. This document consists of a 
      description of the epidemiology of HF, pharmacology of the drug, clinical trials, 
      use of the drug in cases with reduced ejection fraction, mildly reduced ejection 
      fraction and preserved ejection fraction, available literature on HF guidelines, 
      recommendations and conclusions.
CI  - Copyright: (c) 2023 Permanyer.
FAU - Speranza, Mario
AU  - Speranza M
AD  - Departamento de Cardiologia, Hospital Clinica Biblica, San Jose, Costa Rica.
FAU - Saldarriaga, Clara
AU  - Saldarriaga C
AD  - Departamento de Cardiologia, Clinica Cardio VID, Medellin, Colombia.
FAU - Ramos, Carlos E
AU  - Ramos CE
AD  - Departamento de Cardiologia, Instituto Nacional Cardiopulmonar, Tegucigalpa, 
      Honduras.
FAU - Quesada, Daniel
AU  - Quesada D
AD  - Departamento de Cardiologia, Hospital San Vicente de Paul, Heredia, Costa Rica.
FAU - Rossel, Victor
AU  - Rossel V
AD  - Departamento de Cardiologia, Hospital del Salvador.
AD  - Facultad de Medicina, Universidad de Chile, Santiago, Chile.
FAU - Ventura-Umanzor, Jaime R
AU  - Ventura-Umanzor JR
AD  - Departamento de Cardiologia, Instituto Salvadoreno del Seguro Social, San 
      Salvador, El Salvador.
FAU - Pow-Chon, Freddy
AU  - Pow-Chon F
AD  - Departamento de Cardiologia, Hospital Luis Vernaza.
AD  - Departamento de Cardiologia, Universidad Espiritu Santo, Guayaquil, Ecuador.
FAU - Alarco, Walter
AU  - Alarco W
AD  - Departamento de Cardiologia, Instituto Nacional Cardiovascular, Lima, Peru.
FAU - Figueroa, Yolanda
AU  - Figueroa Y
AD  - Departamento de Cardiologia, Legacy Medical Center, Humacao, Puerto Rico.
FAU - Magana, Antonio
AU  - Magana A
AD  - Departamento de Cardiologia, Centro Medico Nacional Siglo XXI, Instituto Mexicano 
      del Seguro Social, Ciudad de Mexico, Mexico.
FAU - Gomez-Mesa, Juan E
AU  - Gomez-Mesa JE
AD  - Departamento de Cardiologia, Fundacion Valle de Lili, Cali, Colombia.
FAU - Rodriguez-Garcia, David
AU  - Rodriguez-Garcia D
AD  - Departamento de Cardiologia, Hospital Herrera Llerandi, Guatemala.
LA  - eng
PT  - Journal Article
TT  - Documento de consenso sobre el uso de sacubitrilo/valsartan en pacientes con 
      insuficiencia cardiaca: Consejo Interamericano de Falla Cardiaca e Hipertension 
      Pulmonar (CIFACAH) de la Sociedad Interamericana de Cardiologia (SIAC).
PL  - Mexico
TA  - Arch Cardiol Mex
JT  - Archivos de cardiologia de Mexico
JID - 101126728
RN  - 17ERJ0MKGI (sacubitril)
RN  - 0 (Tetrazoles)
RN  - 0 (Angiotensin Receptor Antagonists)
RN  - 80M03YXJ7I (Valsartan)
SB  - IM
MH  - Humans
MH  - United States
MH  - Quality of Life
MH  - Consensus
MH  - Tetrazoles/adverse effects
MH  - Stroke Volume
MH  - Angiotensin Receptor Antagonists/therapeutic use
MH  - Valsartan/adverse effects
MH  - *Heart Failure/drug therapy
MH  - *Ventricular Dysfunction, Left
MH  - *Cardiology
MH  - *Hypertension/drug therapy
PMC - PMC10665007
OTO - NOTNLM
OT  - Consenso
OT  - Consensus
OT  - Heart failure
OT  - Insuficiencia cardiaca
OT  - Sacubitril-valsartan
OT  - Sacubitrilo-valsartan
COIS- Ninguno.
EDAT- 2023/11/03 00:42
MHDA- 2023/11/06 06:43
PMCR- 2023/10/27
CRDT- 2023/11/02 19:43
PHST- 2023/11/06 06:43 [medline]
PHST- 2023/11/03 00:42 [pubmed]
PHST- 2023/11/02 19:43 [entrez]
PHST- 2023/10/27 00:00 [pmc-release]
AID - j93/Supl/1 [pii]
AID - 7974AX231-ACM-93-1 [pii]
AID - 10.24875/ACM.23000036 [doi]
PST - ppublish
SO  - Arch Cardiol Mex. 2023;93(Supl):1-12. doi: 10.24875/ACM.23000036.